Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-14-011253
Filing Date
2014-06-16
Accepted
2014-06-16 16:11:58
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K ombp20140523_10k.htm 10-K 1917073
2 EXHIBIT 21 ex21.htm EX-21 4472
3 EXHIBIT 31.1 ex31-1.htm EX-31 11823
4 EXHIBIT 32.1 ex32-1.htm EX-32 6874
  Complete submission text file 0001437749-14-011253.txt   9076073

Data Files

Seq Description Document Type Size
5 EXHIBIT 101.INS ombp-20140331.xml EX-101.INS 1102268
6 EXHIBIT 101.SCH ombp-20140331.xsd EX-101.SCH 70897
7 EXHIBIT 101.CAL ombp-20140331_cal.xml EX-101.CAL 21529
8 EXHIBIT 101.DEF ombp-20140331_def.xml EX-101.DEF 357902
9 EXHIBIT 101.LAB ombp-20140331_lab.xml EX-101.LAB 511354
10 EXHIBIT 101.PRE ombp-20140331_pre.xml EX-101.PRE 349497
Mailing Address 181 W BOARDWALK DRIVE SUITE 202 FORT COLLINS CO 80525
Business Address 181 W BOARDWALK DRIVE SUITE 202 FORT COLLINS CO 80525 970-237-5178
OMNI BIO PHARMACEUTICAL, INC. (Filer) CIK: 0001389870 (see all company filings)

EIN.: 208097969 | State of Incorp.: CO | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 000-52530 | Film No.: 14922899
SIC: 2836 Biological Products, (No Diagnostic Substances)